$3.86 6%
ALDX Stock Price vs. AI Score (Last 150 days)
Data gathered: July 13

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Aldeyra Therapeutics

Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated diseases.


Aldeyra Therapeutics
Price $3.86
Target Price Sign up
Volume 319,640
Market Cap $229M
Year Range $2.21 - $4.72
Dividend Yield 0%
Revenue per Employee $26,175
Industry Biotechnology

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '2403.2M-3.7M-8.1M-9.3M-0.140
Q4 '23390,0001.8M-2.3M-4.7M-6M-0.080
Q3 '2302.6M-3.1M-8.2M-7.6M-0.140
Q2 '2303.4M-3.9M-9M-8.4M-0.150
Q1 '2305.6M-6.1M-16M-15M-0.270

Insider Transactions View All

EDELMAN JOSEPH filed to buy 9,275,851 shares at $4.7.
April 8 '24
EDELMAN JOSEPH filed to buy 9,238,139 shares at $4.7.
April 8 '24
EDELMAN JOSEPH filed to buy 9,097,858 shares at $4.1.
April 3 '24
EDELMAN JOSEPH filed to buy 8,788,011 shares at $3.4.
April 3 '24
EDELMAN JOSEPH filed to buy 8,601,960 shares at $3.3.
April 3 '24

What is the Market Cap of Aldeyra Therapeutics?

The Market Cap of Aldeyra Therapeutics is $229M.

How Many People Work at Aldeyra Therapeutics?

As of our latest update, Aldeyra Therapeutics employed approximately 15 people worldwide. However, it's important to note that Aldeyra Therapeutics' workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Aldeyra Therapeutics' revenue per employee?

$26,175. To calculate Aldeyra Therapeutics' revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current stock price of Aldeyra Therapeutics?

Currently, the price of one share of Aldeyra Therapeutics stock is $3.86.

How can I analyze the ALDX stock price chart for investment decisions?

The ALDX stock price chart above provides a comprehensive visual representation of Aldeyra Therapeutics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Aldeyra Therapeutics shares. Our platform offers an up-to-date ALDX stock price chart, along with technical data analysis and alternative data insights.

Does ALDX offer dividends to its shareholders?

As of our latest update, Aldeyra Therapeutics (ALDX) does not offer dividends to its shareholders. Investors interested in Aldeyra Therapeutics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Aldeyra Therapeutics?

Some of the similar stocks of Aldeyra Therapeutics are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.